Anatomical Molecular Laboratory

Introduction

The Anatomical Molecular Laboratory (ATOM)(former Translational Pathology Centre or TPC) is a molecular laboratory under the Department of Anatomical Pathology. It offers next generation sequencing tests for molecular profiling of various cancers / tumours, either on tumour tissue or on cell free nucleic acids in the peripheral blood (liquid biopsy).

ATOM currently offers two clinical tests:

The test menu will be progressively expanded over time.

Somatic Solid Tumour Panel (SSTP) assay

The SSTP assay is a small panel amplicon-based next generation sequencing (NGS) assay that can detect single nucleotide variants (SNVs) and short insertion/deletions (delins) in 15 to 18 genes. It can be used for mutational testing of lung cancers, colorectal cancers, gastrointestinal stromal tumours (GISTs), melanomas and other solid tumours where the genomic alterations covered by the assay is relevant. It does not cover copy number variations (CNVs), gene fusions or other genomic alterations.

While the assay is subdivided into Lung, Colon and GIST / Melanoma panels for these tumour types, other tumour types can also be tested using any of these panels as long as the relevant genes of interest are covered. For example, mutational testing for PIK3CA, AKT1 and PTEN in breast cancers or IDH1, IDH2 and BRAF in brain tumours can be performed using the SSTP Lung panel as these genes are included in the panel. Similarly, POLE testing for endometrial cancers can also be performed using the SSTP Lung panel as it covers the POLE gene.

The list of genes, specimen requirements and other details of the assay can be found in the link below:

Click here to view more details on SSTP assay

Somatic Solid Tumour Liquid Panel (SSTP Liquid) assay

The SSTP Liquid assay is an amplicon based next generation sequencing (NGS) assay incorporated with molecular tagging that allows sensitive detection of circulating cell-free tumour nucleic acids in the peripheral blood (liquid biopsy). Only SNVs and short delins are validated for this assay. This assay can be used to determine the presence of genomic alterations in circulating tumour nucleic acids in patients that would predict response of a cancer to targeted therapy (predictive testing).

The list of genes, specimen requirements and other details of the assay can be found in the link below:

Click here to view more details on SSTP Liquid assay

Click here to view CPOE ordering instructions for SSTP Liquid (for relevant SingHealth institutions)

Specimen Request Form Requirements for All Specimens

All specimens are to be accompanied by a hard copy test request form or an electronic test request order in the Computerised Physician Order Entry system (CPOE) (for relevant SingHealth institutions). The hard copy request form or CPOE order should include the following information:

Patient's name, NRIC/passport number, visit account number, age, sex, date of birth
Hospital, department and ward number, or name of clinic with telephone / fax number
Clinical Diagnosis (including primary site of cancer)
Clinical History / relevant clinical information, including any previous treatment rendered
Nature of specimen (including paraffin block number for tissue specimens), nature of procedure/operation, anatomical site, and date and time specimen was taken
Name of consultant-in-charge / doctor performing procedure, their MCR number and telephone number

Translational / Research Work

Besides clinical testing, the laboratory has other capabilities that are used in the translational / research space:

DNA / RNA extraction
PCR based assays
Sanger sequencing
Digital droplet PCR
Next generation sequencing

Laboratory Operating Hours & Contact Details

Monday – Friday: 8.30am – 5.30pm

Address: 20 College Road, Academia building, Ngee Ann Kongsi Discovery Tower Level 10, Anatomical Molecular Laboratory (ATOM), Department of Anatomical Pathology, Singapore General Hospital, Singapore 169856

Telephone: (65) 6576 7191

Fax: (65) 6227 6562